ArticleFrontiers in bioinformatics2026
Geometric multidimensional representation of omic signatures.
Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A pan-cancer multi-omicFrontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Multi-omic signatures are widely used in biomarker discovery, precision oncology, and systems biology, yet they are typically treated as vectors or composite scores that collapse intrinsically multidimensional biological organization into one-dimensional summaries. As a result, their internal structure, contextual dependencies, and functional coherence remain largely inaccessible. Methods: Here, we introduce a geometric framework that reconceptualizes omic signatures as multidimensional informational entities whose biological meaning arises from structural organization rather than molecular membership alone. Each signature is embedded in a shared latent space integrating regulatory, phenotypic, microenvironmental, immune, and clinical constraints, and represented as a convex polytope. This representation preserves internal organization and enables intrinsic geometric measurements-including barycenter distance, volume, anisotropy, and asymmetry-that quantify concordance, divergence, and latent complexity. We applied this framework to 24,796 metabolic regulatory circuitries reconstructed across 32 TCGA cancer types, encoded as paired regulatory and metabolic signatures in an 18-dimensional latent space. Results: Geometric analysis shows that discordance predominates: most circuitries occupy strong or extreme discordance regimes and display high-dimensional, frequently asymmetric geometries, whereas fully concordant circuitries are rare and structurally constrained. These geometric phenotypes stratify metabolic pathways and superfamilies in reproducible, non-uniform patterns that are not readily captured by conventional vector- or network-based representations. Discussion: By transforming omic signatures into measurable geometric objects, this framework provides a principled approach for the comparison and de-redundancy of multi-omic biomarkers, providing a scalable method for analyzing complex regulatory systems across cancer and beyond. All geometric representations and derived descriptors are available through the SigPolytope Shiny application (https://sigpolytope.shinyapps.io/geometricatlas/).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.